Total Payments
$1,542
2022 Payments
$50.23
Companies
12
Transactions
32
Medicare Patients
991
Medicare Billing
$118,178
Payment Breakdown by Category
Food & Beverage$1,532 (99.3%)
Education$10.24 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,532 | 31 | 99.3% |
| Education | $10.24 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $302.02 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $299.17 | 3 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $281.57 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.91 | 2 | $0 (2017) |
| Amarin Pharma Inc. | $154.78 | 3 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $126.11 | 2 | $0 (2017) |
| Novo Nordisk Inc | $62.80 | 1 | $0 (2017) |
| Bard Peripheral Vascular, Inc. | $27.53 | 2 | $0 (2022) |
| Teleflex LLC | $22.70 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $19.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $50.23 | 3 | Bard Peripheral Vascular, Inc. ($27.53) |
| 2021 | $18.05 | 1 | AbbVie Inc. ($18.05) |
| 2020 | $23.14 | 1 | Amarin Pharma Inc. ($23.14) |
| 2019 | $92.46 | 3 | SANOFI-AVENTIS U.S. LLC ($67.50) |
| 2018 | $290.83 | 7 | AbbVie, Inc. ($225.42) |
| 2017 | $1,067 | 17 | AstraZeneca Pharmaceuticals LP ($233.76) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2022 | Teleflex LLC | QuikClot (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Emergency Medicine | ||||||
| 10/08/2022 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 04/02/2022 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/04/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardiovascular | ||||||
| 09/27/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 08/21/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Endocrinology | ||||||
| 12/21/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $5.20 | General |
| 10/25/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $109.48 | General |
| Category: Endocrinology | ||||||
| 09/20/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $2.06 | General |
| 08/07/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $102.44 | General |
| 06/04/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $3.38 | General |
| Category: Endocrinology | ||||||
| 01/31/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $65.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Endocrinology | ||||||
| 12/07/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $71.65 | General |
| Category: DIABETES | ||||||
| 08/23/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug), OXYCONTIN | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/08/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Endocrinology | ||||||
| 05/03/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $84.95 | General |
| Category: DIABETES | ||||||
| 04/12/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $63.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Endocrinology | ||||||
| 04/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $89.91 | General |
| 04/04/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $57.47 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 279 | 501 | $69,406 | $33,627 |
| 2022 | 7 | 268 | 475 | $67,375 | $31,856 |
| 2021 | 5 | 211 | 441 | $57,148 | $30,123 |
| 2020 | 5 | 233 | 433 | $42,632 | $22,571 |
Total Patients
991
Total Services
1,850
Medicare Billing
$118,178
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 300 | $36,000 | $17,733 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 97 | $17,848 | $8,325 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $9,165 | $4,938 | 53.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,828 | $1,444 | 29.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $690.00 | $676.20 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 25 | 25 | $875.00 | $511.50 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 298 | $35,760 | $16,580 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 64 | $11,776 | $5,514 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $8,930 | $4,938 | 55.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $4,900 | $2,318 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,544 | $1,396 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $660.00 | $648.50 | 98.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 23 | 23 | $805.00 | $461.45 | 57.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 318 | $37,170 | $19,712 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 38 | 38 | $8,930 | $5,055 | 56.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 57 | $10,138 | $4,826 | 47.6% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 14 | 14 | $490.00 | $278.00 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $420.00 | $252.40 | 60.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 96 | 278 | $25,020 | $13,295 | 53.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 68 | $9,112 | $4,932 | 54.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $6,580 | $3,257 | 49.5% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 29 | 30 | $1,050 | $573.41 | 54.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 28 | 29 | $870.00 | $514.39 | 59.1% |
About Dr. Bryan Chan, MD
Dr. Bryan Chan, MD is a Acupuncturist healthcare provider based in Upland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417059957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Chan, MD has received a total of $1,542 in payments from pharmaceutical and medical device companies, with $50.23 received in 2022. These payments were reported across 32 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,532).
As a Medicare-enrolled provider, Chan has provided services to 991 Medicare beneficiaries, totaling 1,850 services with total Medicare billing of $118,178. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Acupuncturist
- Other Specialties Homeopath, Family Medicine
- Location Upland, CA
- Active Since 09/04/2006
- Last Updated 06/14/2023
- Taxonomy Code 171100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417059957
Products in Payments
- BYDUREON (Drug) $190.40
- Creon (Drug) $174.27
- Vascepa (Drug) $154.78
- SOLIQUA (Drug) $129.12
- INVOKANA (Drug) $126.11
- JARDIANCE (Drug) $125.00
- FARXIGA (Drug) $108.77
- TOUJEO (Drug) $84.95
- SOLIQUA 100/33 (Drug) $67.50
- Tresiba (Drug) $62.80
- Venclose Maven Catheter (Device) $27.53
- QuikClot (Device) $22.70
- ENTRESTO (Drug) $19.71
- HYSINGLA ER (Drug) $18.46
- CREON (Drug) $18.05
- LYRICA (Drug) $12.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acupuncturist Doctors in Upland
Mrs. Wenzhong Tang, Lac, LAC
Acupuncturist
Acupuncturist
Ms. Kathlyn Cui, O.m.d, O.M.D
Acupuncturist
Acupuncturist
Dr. Ray Chen, L.ac., O.m.d., Ph.d, L.AC., O.M.D., PH.D
Acupuncturist
Acupuncturist
Xiao Kang Peter Chen
Acupuncturist
Acupuncturist
Mr. Alfredo Lozano, L,Ac, L,AC
Acupuncturist
Acupuncturist
Mrs. Juanfang Wang
Acupuncturist
Acupuncturist